Ex-FDA Commissioner Privately Told CIA That Up to 25% of Americans Had Already Achieved Natural Immunity Through Exposure to COVID by May 2020, Unclassified Document Reveals

Newly released documents are raising explosive questions about what pharmaceutical insiders and America’s intelligence community knew about COVID-19 immunity during the earliest months of the pandemic and why Americans were hearing a dramatically different story in public.

Senator Rand Paul (R-KY) released records detailing a May 7, 2020, CIA briefing involving Dr. Scott Gottlieb, the former FDA commissioner who had joined Pfizer’s board of directors the previous year.

Paul announced on X:

“I released documents showing Pfizer and the CIA privately acknowledged high population immunity as early as May 2020, while the public heard a different story. Americans deserve the truth.”

He pointed to reporting at Brownstone Institute on a newly unclassified CIA meeting summary buried in the latest tranche of records Paul entered into the congressional record.

The date on the briefing is May 7, 2020.

That is two months after the country was shut down. Churches closed. Small businesses crushed. Kids locked out of school. Fauci and Deborah Birx still talking as if this was a rare, novel threat that required indefinite emergency rule until a pharmaceutical product arrived.

Inside the CIA, they were already talking seroprevalence. Seroprevalence is the percentage or proportion of people in a specific population who have antibodies against a specific disease or infectious agent in their blood serum.

According to the agency’s own write-up of the meeting, CIA Chief Operating Officer Andy Makridis sat down with Dr. Scott Gottlieb. Gottlieb was not some outside critic. He was a former FDA commissioner, a sitting Pfizer board member, and a member of the CIA’s External Advisory Board. One man. Three hats. Vaccine company. Spy agency. Former regulator.

The CIA summary records Gottlieb’s assessment on herd immunity:

On “herd immunity” Dr. Gottlieb discounts the 2 major studies from Los Angeles and Santa Clara counties showing high seroprevalence. He believes nationally, the seroprevalence is about 20-25% which is insufficient for herd immunity at the R₀ (BRR) value of 3.

In other words, Gottlieb was telling CIA officials in May 2020 that as many as one in four Americans had already achieved natural immunity.

But the public did hear a different story.

During an August 16, 2020, appearance on CBS’s Face the Nation, Gottlieb claimed that only about 8% of the country had been exposed and declared that America was “probably a long way” from herd immunity.

That public estimate came more than three months after the CIA briefing and was dramatically lower than the 20% to 25% figure attributed to Gottlieb in the agency’s internal summary.

Brownstone Institute founder Jeffrey Tucker, who first highlighted the passage, noted that Gottlieb was simultaneously connected to Pfizer and the CIA while serving as one of the country’s most influential public voices on the pandemic.

Pfizer officially elected Gottlieb to its board in June 2019, less than one year before the CIA briefing.

Tucker argued that the document raises serious questions about whether officials believed population immunity was accumulating much faster than they publicly acknowledged.

In August 2021, The Gateway Pundit reported that a new study out of Israel has seemingly confirmed that individuals who have natural immunity have better protection against the new COVID variant than people who are fully vaccinated.

Not just a little bit better either. People who have taken both doses of the Pfizer jab are 13 TIMES more likely to have a breakthrough infection, and are even at a “greater risk for Covid-19 hospitalizations.”

The researchers conducted an extensive study on 800,000 individuals that were broken into 3 groups. People who had received either one or two doses of the Pfizer-BioNTech COVID-19 vaccine were compared with unvaccinated individuals who have natural immunity, because they had already recovered from the virus.

In October 2021, alarming data released by a government-funded project showed that the effectiveness of both the Pfizer and Moderna mRNA COVID-19 vaccines significantly waned over time.  The effects lessen in any fully vaccinated individuals with each passing week.

An AI program launched by the Dept. of Defense’s Joint Artificial Intelligence Center (JAIC) called “Project Salus” has examined data on 5.6 million Medicare beneficiaries aged 65 and older, 2.7M were vaccinated with Pfizer, and 2.9M with Moderna. The data was posted on October 5th on the Humetrix website, a platform that provides healthcare organizations and government agencies with real-time clinical data management.

This new finding revealed that the majority of those 5.6 million Medicare beneficiaries aged 65+ who are fully vaccinated were infected by COVID-19.  This means that transmission may be primarily occurring by vaccinated individuals.

Two studies from Israel and Qatar that were published in the New England Journal of Medicine supported this claim that the effectiveness of the vaccine decreases over time despite the individuals being fully vaccinated.

On the same month, The Gateway Pundit reported that 91 clinical research studies all confirmed that natural immunity provides the same if not better protection against the virus than Covid-19 vaccines.

According to the article, the Brownstone Institute for Social and Economic Research published a list of 91 different clinical research studies which each conclude that naturally acquired immunity is at the very least equal to, but in many cases vastly superior, to the experimental mRNA vaccines that are currently available.

Most notably, of the almost 1,400 “previously infected subjects” who had never received a Covid-19 vaccine, not a single one was reinfected with the virus. The data was so clear that researchers concluded vaccination is “unlikely to benefit” individuals with natural immunity. Read the rest here.

In January 2022, a new report from the Centers for Disease Control and Prevention (CDC) found that unvaccinated people who had recovered from COVID-19 were better protected than those who were vaccinated and had not previously been infected during the recent delta surge.

The researchers evaluated the data from 1.1 million Covid-19 cases among adults in California and New York (which account for 18% of the U.S. population) from May 30 to Nov. 20, 2021.

Then, in May 2022, a new study conducted by scientists from the National Institutes of Health (NIH) and Moderna Inc. showed that mRNA vaccines hurt the long-term immunity to Covid-19 after contracting infection compared to unvaccinated people.